Titre : Hépatite chronique

Hépatite chronique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hépatite chronique : Questions médicales les plus fréquentes", "headline": "Hépatite chronique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hépatite chronique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-22", "dateModified": "2025-02-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hépatite chronique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladie chronique", "url": "https://questionsmedicales.fr/mesh/D002908", "about": { "@type": "MedicalCondition", "name": "Maladie chronique", "code": { "@type": "MedicalCode", "code": "D002908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hépatite B chronique", "alternateName": "Hepatitis B, Chronic", "url": "https://questionsmedicales.fr/mesh/D019694", "about": { "@type": "MedicalCondition", "name": "Hépatite B chronique", "code": { "@type": "MedicalCode", "code": "D019694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.500" } } }, { "@type": "MedicalWebPage", "name": "Hépatite C chronique", "alternateName": "Hepatitis C, Chronic", "url": "https://questionsmedicales.fr/mesh/D019698", "about": { "@type": "MedicalCondition", "name": "Hépatite C chronique", "code": { "@type": "MedicalCode", "code": "D019698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.750" } } }, { "@type": "MedicalWebPage", "name": "Hépatite D chronique", "alternateName": "Hepatitis D, Chronic", "url": "https://questionsmedicales.fr/mesh/D019701", "about": { "@type": "MedicalCondition", "name": "Hépatite D chronique", "code": { "@type": "MedicalCode", "code": "D019701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Hépatite chronique", "alternateName": "Hepatitis, Chronic", "code": { "@type": "MedicalCode", "code": "D006521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Heiner Wedemeyer", "url": "https://questionsmedicales.fr/author/Heiner%20Wedemeyer", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hanover, Hanover, Germany." } }, { "@type": "Person", "name": "Grace Lai-Hung Wong", "url": "https://questionsmedicales.fr/author/Grace%20Lai-Hung%20Wong", "affiliation": { "@type": "Organization", "name": "Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Giuseppina Brancaccio", "url": "https://questionsmedicales.fr/author/Giuseppina%20Brancaccio", "affiliation": { "@type": "Organization", "name": "Infectious Diseases, Department of Molecular Medicine, University of Padua, Padua, Italy." } }, { "@type": "Person", "name": "Giovanni B Gaeta", "url": "https://questionsmedicales.fr/author/Giovanni%20B%20Gaeta", "affiliation": { "@type": "Organization", "name": "Infectious Diseases, Department of Mental and Physical Health, Campania University, Naples, Italy. Electronic address: giovannibattista.gaeta@unicampania.it." } }, { "@type": "Person", "name": "Maria Buti", "url": "https://questionsmedicales.fr/author/Maria%20Buti", "affiliation": { "@type": "Organization", "name": "Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of the national hepatitis B immunization program in China: a modeling study.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36221140", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40249-022-01032-5" } }, { "@type": "ScholarlyArticle", "name": "Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.", "datePublished": "2024-06-10", "url": "https://questionsmedicales.fr/article/38857859", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2024.2357439" } }, { "@type": "ScholarlyArticle", "name": "Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36503856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2022.11.074" } }, { "@type": "ScholarlyArticle", "name": "Investigation of non-National Immunization Program vaccination intentions in rural areas of China.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37542236", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16390-4" } }, { "@type": "ScholarlyArticle", "name": "Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.", "datePublished": "2023-10-31", "url": "https://questionsmedicales.fr/article/37956381", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3855/jidc.17886" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Caractéristiques de la maladie", "item": "https://questionsmedicales.fr/mesh/D020969" }, { "@type": "ListItem", "position": 5, "name": "Maladie chronique", "item": "https://questionsmedicales.fr/mesh/D002908" }, { "@type": "ListItem", "position": 6, "name": "Hépatite chronique", "item": "https://questionsmedicales.fr/mesh/D006521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hépatite chronique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hépatite chronique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hépatite chronique", "description": "Comment diagnostiquer l'hépatite chronique ?\nQuels tests sanguins sont utilisés ?\nQu'est-ce qu'une biopsie hépatique ?\nQuels sont les signes d'hépatite chronique ?\nL'échographie est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Immunization+Programs&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hépatite chronique", "description": "Quels sont les symptômes courants ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?\nLes démangeaisons sont-elles fréquentes ?\nY a-t-il des symptômes psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Immunization+Programs&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hépatite chronique", "description": "Comment prévenir l'hépatite chronique ?\nLa vaccination est-elle efficace ?\nQuels comportements à risque éviter ?\nL'hygiène joue-t-elle un rôle ?\nLes tests de dépistage sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Immunization+Programs&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hépatite chronique", "description": "Quels traitements existent pour l'hépatite chronique ?\nLes antiviraux sont-ils efficaces ?\nQuand faut-il envisager une transplantation ?\nY a-t-il des traitements naturels ?\nComment surveiller l'évolution de la maladie ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Immunization+Programs&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hépatite chronique", "description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nQuels signes indiquent une insuffisance hépatique ?\nLe cancer du foie est-il fréquent ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Immunization+Programs&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hépatite chronique", "description": "Quels sont les principaux facteurs de risque ?\nL'usage de drogues augmente-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes voyages à l'étranger sont-ils un risque ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Immunization+Programs&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hépatite chronique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, des échographies et parfois une biopsie hépatique." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les marqueurs viraux, les enzymes hépatiques et les tests de fonction hépatique." } }, { "@type": "Question", "name": "Qu'est-ce qu'une biopsie hépatique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un prélèvement de tissu hépatique pour évaluer l'inflammation et les lésions." } }, { "@type": "Question", "name": "Quels sont les signes d'hépatite chronique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes peuvent inclure fatigue, jaunisse, douleurs abdominales et démangeaisons." } }, { "@type": "Question", "name": "L'échographie est-elle utile ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie permet de visualiser des anomalies du foie et d'évaluer sa taille." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit." } }, { "@type": "Question", "name": "La jaunisse est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la jaunisse se manifeste par une coloration jaune de la peau et des yeux." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes asymptomatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent être asymptomatiques malgré une hépatite chronique." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les démangeaisons peuvent survenir en raison de l'accumulation de bile dans le sang." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété et la dépression peuvent être des symptômes associés à l'hépatite chronique." } }, { "@type": "Question", "name": "Comment prévenir l'hépatite chronique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination, l'hygiène et l'évitement des comportements à risque sont essentiels." } }, { "@type": "Question", "name": "La vaccination est-elle efficace ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre l'hépatite A et B est très efficace pour prévenir ces infections." } }, { "@type": "Question", "name": "Quels comportements à risque éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez le partage d'aiguilles, les rapports sexuels non protégés et l'usage de drogues." } }, { "@type": "Question", "name": "L'hygiène joue-t-elle un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle et alimentaire peut réduire le risque d'infection." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage régulier est crucial pour détecter l'hépatite chronique tôt." } }, { "@type": "Question", "name": "Quels traitements existent pour l'hépatite chronique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des antiviraux, des immunomodulateurs et des soins de soutien." } }, { "@type": "Question", "name": "Les antiviraux sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antiviraux peuvent réduire la charge virale et améliorer la fonction hépatique." } }, { "@type": "Question", "name": "Quand faut-il envisager une transplantation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications graves." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements naturels peuvent aider, mais ils doivent être discutés avec un médecin." } }, { "@type": "Question", "name": "Comment surveiller l'évolution de la maladie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des tests sanguins et des échographies sont nécessaires." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique." } }, { "@type": "Question", "name": "La cirrhose est-elle réversible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la cirrhose est une condition irréversible, mais son évolution peut être ralentie." } }, { "@type": "Question", "name": "Quels signes indiquent une insuffisance hépatique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent confusion, saignements, jaunisse et accumulation de liquide abdominal." } }, { "@type": "Question", "name": "Le cancer du foie est-il fréquent ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le cancer du foie peut survenir chez les patients atteints d'hépatite chronique." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'infection virale, l'alcoolisme, et certaines maladies auto-immunes." } }, { "@type": "Question", "name": "L'usage de drogues augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de drogues injectables augmente le risque d'hépatite chronique." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'hépatite peuvent augmenter le risque de développer la maladie." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains groupes de sexe peuvent avoir un risque plus élevé d'infection virale." } }, { "@type": "Question", "name": "Les voyages à l'étranger sont-ils un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions à forte prévalence d'hépatite peut augmenter le risque d'infection." } } ] } ] }

Sources (10000 au total)

Impact of the national hepatitis B immunization program in China: a modeling study.

Elimination of hepatitis B virus (HBV) is a striking challenge for countries with high or moderate disease burden. Therefore, using China as a practical case to share experiences for similar countries... We constructed an expanded Susceptible-Exposed-Infectious-Recovered (SEIR) model and decision tree-Markov model to estimate the epidemic of HBV in China, assess the feasibility of 2030 Elimination Goa... Between 1990 and 2020, the number of chronic HBV infections decreased by 33.9%. The current status quo would lead to 55.73 million infections (3.95% prevalence) in 2030, compared to 90.63 million (6.4... Our findings proved the HBV vaccination has demonstrated a substantial positive impact on controlling the epidemic of HBV in terms of effectiveness and economy after about 30 years of implementation o...

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new pre...

Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.

Globally, rotavirus is a leading cause of severe acute gastroenteritis among children aged under 5 years and has a significant economic cost. Currently, rotavirus vaccines are only included in the pri... A decision tree Markov model was constructed to evaluate the cost-benefit of universal immunization with three doses of rotavirus vaccine for a 2019 birth cohort of Chinese children. Costs of the univ... For the 2019 birth cohort of Chinese infants, inclusion of RotaTeq in NIP was estimated to prevent 5,677,911 cases of rotavirus infection, with net savings of $1.1 billion in total societal costs. A c... Introducing rotavirus vaccine into the China NIP would have significant costs from a societal perspective at the current private market price....

Investigation of non-National Immunization Program vaccination intentions in rural areas of China.

China's current immunization program was revised in 2007. Some common childhood vaccines such as those for influenza, pediatric pneumonia, Haemophilus influenzae, varicella, and rotavirus have not bee... A qualitative method of in-depth interviews were conducted for this study. We interviewed 30 rural parents in a central Chinese village to investigate their awareness of non-NIP vaccines and their vac... This study summarized the individual and social level factors influencing the non-NIP vaccination intention of rural parents. The individual level factors include four themes: perceived severity with ... Based on these influencing factors, this study constructs a structural model for non-NIP vaccination decision-making process in rural areas of China. The results play a guiding role in directing atten...

Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.

Adherence to full vaccination is important in preventing childhood diseases. The aim of this study was to evaluate the level of compliance to full vaccination and identify the socio-cultural factors a... The socioeconomic variables associated with each of the four binary dependent variables of whether or not a child is fully vaccinated against tetanus, BCG, measles, and pentavalent were determined usi... While compliance to full tetanus and BCG vaccinations was > 60% at the national level, less than 50% and 10% full vaccination compliance were recorded for pentavalent and measles vaccinations, respect... The socio-cultural factors associated with achieving full vaccination coverage in Nigeria in this study should drive the implementation of policies that will be best suited to each geopolitical zone o...

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru.

This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a... A cost-minimization analysis compared the costs associated with vaccine administration, adverse reactions medical treatment, logistical activities, and indirect social costs associated with time spent... Incorporating the hexavalent vaccine would result in a 15.5% net increase in healthcare budget expenditure ($48,281,706 vs $55,744,653). Vaccination costs would increase by 54.1%, whereas logistical a... Despite of the significant reduction of logistical and adverse reaction costs, including the hexavalent vaccine into the National Immunization Program of Peru in place of the current vaccination schem...

Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs.

The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization se... We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine... Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These...